Top

Published in:

Open Access 01-12-2010 | Research

The inflammatory cytokine tumor necrosis factor modulates the expression of Salmonella typhimurium effector proteins

Authors: Jun Ma, Yong-guo Zhang, Yinglin Xia, Jun Sun

Published in: Journal of Inflammation | Issue 1/2010

Abstract

Tumor necrosis factor α (TNF-α)is a host inflammatory factor. Bacteria increase TNF-α expression in a variety of human diseases including infectious diseases, inflammatory bowel diseases, and cancer. It is unknown, however, how TNF-α directly modulates bacterial protein expression during intestinal infection and chronic inflammation. In the current study, we hypothesize that Salmonella typhimurium senses TNF-α and show that TNF-α treatment modulates Salmonella virulent proteins (called effectors), thus changing the host-bacterial interaction in intestinal epithelial cells. We investigated the expression of 23 Salmonella effectors after TNF-α exposure. We found that TNF-α treatment led to differential effector expression: effector SipA was increased by TNF-α treatment, whereas the expression levels of other effectors, including gogB and spvB, decreased in the presence of TNF-α. We verified the protein expression of Salmonella effectors AvrA and SipA by Western blots. Furthermore, we used intestinal epithelial cells as our experimental model to explore the response of human intestinal cells to TNF-α pretreated Salmonella. More bacterial invasion was found in host cells colonized with Salmonella strains pretreated with TNF-α compared to Salmonella without TNF-α treatment. TNF-α pretreated Salmonella induced higher proinflammatory JNK signalling responses compared to the Salmonella strains without TNF-α exposure. Exposure to TNF-α made Salmonella to induce more inflammatory cytokine IL-8 in intestinal epithelial cells. JNK inhibitor treatment was able to suppress the effects of TNF-pretreated-Salmonella in enhancing expressions of phosphorylated-JNK and c-jun and secretion of IL-8. Overall, our study provides new insights into Salmonella-host interactions in intestinal inflammation.

Available only for authorised users

Tracey KJ, Cerami A: Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994, 45: 491-503. 10.1146/annurev.med.45.1.491.PubMedCrossRef

Rahman MM, Lucas AR, McFadden G: Viral TNF inhibitors as potential therapeutics. Adv Exp Med Biol. 2009, 666: 64-77. full_text.PubMedCrossRef

Chouaib S, Robinet E, Zyad A, Branellec D: [Tumor necrosis factor: pleiotropic cytokine]. Bull Cancer. 1992, 79: 935-949.PubMed

Sidhu RS, Bollon AP: Tumor necrosis factor activities and cancer therapy--a perspective. Pharmacol Ther. 1993, 57: 79-128. 10.1016/0163-7258(93)90037-E.PubMedCrossRef

Keane J: TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology (Oxford). 2005, 44: 714-720. 10.1093/rheumatology/keh567.CrossRef

Nash PT, Florin TH: Tumour necrosis factor inhibitors. Med J Aust. 2005, 183: 205-208.PubMed

Zariffard MR, Novak RM, Lurain N, Sha BE, Graham P, Spear GT: Induction of tumor necrosis factor-alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis. 2005, 191: 1913-1921. 10.1086/429922.PubMedCrossRef

Wang J, Barke RA, Charboneau R, Roy S: Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol. 2005, 174: 426-434.PubMedCrossRef

Fejer G, Szalay K, Gyory I, Fejes M, Kusz E, Nedieanu S, Pali T, Schmidt T, Siklodi B, Lazar G: et al., Adenovirus infection dramatically augments lipopolysaccharide-induced TNF production and sensitizes to lethal shock. J Immunol. 2005, 175: 1498-1506.PubMedCrossRef

10.

Turner JD, Langley RS, Johnston KL, Egerton G, Wanji S, Taylor MJ: Wolbachia endosymbiotic bacteria of Brugia malayi mediate macrophage tolerance to TLR- and CD40-specific stimuli in a MyD88/TLR2-dependent manner. J Immunol. 2006, 177: 1240-1249.PubMedCrossRef

11.

Hughes DT, Sperandio V: Inter-kingdom signalling: communication between bacteria and their hosts. Nat Rev Microbiol. 2008, 6: 111-120. 10.1038/nrmicro1836.PubMedPubMedCentralCrossRef

12.

Miller ST, Xavier KB, Campagna SR, Taga ME, Semmelhack MF, Bassler BL, Hughson FM: Salmonella typhimurium recognizes a chemically distinct form of the bacterial quorum-sensing signal AI-2. Mol Cell. 2004, 15: 677-687. 10.1016/j.molcel.2004.07.020.PubMedCrossRef

13.

Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB: Bacteria-host communication: the language of hormones. Proc Natl Acad Sci USA. 2003, 100: 8951-8956. 10.1073/pnas.1537100100.PubMedPubMedCentralCrossRef

14.

Boyen F, Eeckhaut V, Van Immerseel F, Pasmans F, Ducatelle R, Haesebrouck F: Quorum sensing in veterinary pathogens: mechanisms, clinical importance and future perspectives. Vet Microbiol. 2009, 135: 187-195. 10.1016/j.vetmic.2008.12.025.PubMedCrossRef

15.

Mota LJ, Cornelis GR: The bacterial injection kit: type III secretion systems. Ann Med. 2005, 37: 234-249. 10.1080/07853890510037329.PubMedCrossRef

16.

Coburn B, Sekirov I, Finlay BB: Type III secretion systems and disease. Clin Microbiol Rev. 2007, 20: 535-549. 10.1128/CMR.00013-07.PubMedPubMedCentralCrossRef

17.

Coburn B, Li Y, Owen D, Vallance BA, Finlay BB: Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect Immun. 2005, 73: 3219-3227. 10.1128/IAI.73.6.3219-3227.2005.PubMedPubMedCentralCrossRef

18.

Mattoo S, Lee YM, Dixon JE: Interactions of bacterial effector proteins with host proteins. Curr Opin Immunol. 2007, 19: 392-401. 10.1016/j.coi.2007.06.005.PubMedCrossRef

19.

McGhie EJ, Brawn LC, Hume PJ, Humphreys D, Koronakis V: Salmonella takes control: effector-driven manipulation of the host. Curr Opin Microbiol. 2009, 12: 117-124. 10.1016/j.mib.2008.12.001.PubMedPubMedCentralCrossRef

20.

Coombes BK, Wickham ME, Brown NF, Lemire S, Bossi L, Hsiao WW, Brinkman FS, Finlay BB: Genetic and molecular analysis of GogB, a phage-encoded type III-secreted substrate in Salmonella enterica serovar typhimurium with autonomous expression from its associated phage. J Mol Biol. 2005, 348: 817-830. 10.1016/j.jmb.2005.03.024.PubMedCrossRef

21.

Xu X, Hensel M: Systematic analysis of the SsrAB virulon of Salmonella enterica. Infect Immun. 78: 49-58. 10.1128/IAI.00931-09.

22.

Browne SH, Hasegawa P, Okamoto S, Fierer J, Guiney DG: Identification of Salmonella SPI-2 secretion system components required for SpvB-mediated cytotoxicity in macrophages and virulence in mice. FEMS Immunol Med Microbiol. 2008, 52: 194-201. 10.1111/j.1574-695X.2007.00364.x.PubMedCrossRef

23.

Raffatellu M, Wilson RP, Chessa D, Andrews-Polymenis H, Tran QT, Lawhon S, Khare S, Adams LG, Baumler AJ: SipA, SopA, SopB, SopD, and SopE2 contribute to Salmonella enterica serotype typhimurium invasion of epithelial cells. Infect Immun. 2005, 73: 146-154. 10.1128/IAI.73.1.146-154.2005.PubMedPubMedCentralCrossRef

24.

Schlumberger MC, Kappeli R, Wetter M, Muller AJ, Misselwitz B, Dilling S, Kremer M, Hardt WD: Two newly identified SipA domains (F1, F2) steer effector protein localization and contribute to Salmonella host cell manipulation. Mol Microbiol. 2007, 65: 741-760. 10.1111/j.1365-2958.2007.05823.x.PubMedCrossRef

25.

Hardt WD, Galan JE: A secreted Salmonella protein with homology to an avirulence determinant of plant pathogenic bacteria. Proc Natl Acad Sci USA. 1997, 94: 9887-9892. 10.1073/pnas.94.18.9887.PubMedPubMedCentralCrossRef

26.

Ben-Barak Z, Streckel W, Yaron S, Cohen S, Prager R, Tschape H: The expression of the virulence-associated effector protein gene avrA is dependent on a Salmonella enterica-specific regulatory function. Int J Med Microbiol. 2006, 296: 25-38. 10.1016/j.ijmm.2005.08.004.PubMedCrossRef

27.

Streckel W, Wolff AC, Prager R, Tietze E, Tschape H: Expression profiles of effector proteins SopB, SopD1, SopE1, and AvrA differ with systemic enteric, and epidemic strains of Salmonella enterica. Mol Nutr Food Res. 2004, 48: 496-503. 10.1002/mnfr.200400035.PubMedCrossRef

28.

Du F, Galan JE: Selective inhibition of type III secretion activated signaling by the Salmonella effector AvrA. PLoS Pathog. 2009, 5: e1000595-10.1371/journal.ppat.1000595.PubMedPubMedCentralCrossRef

29.

Jones RM, Wu H, Wentworth C, Luo L, Collier-Hyams L, Neish AS: Salmonella AvrA Coordinates Suppression of Host Immune and Apoptotic Defenses via JNK Pathway Blockade. Cell Host Microbe. 2008, 3: 233-244. 10.1016/j.chom.2008.02.016.PubMedCrossRef

30.

Liao AP, Petrof EO, Kuppireddi S, Zhao Y, Xia Y, Claud EC, Sun J: Salmonella type III effector AvrA stabilizes cell tight junctions to inhibit inflammation in intestinal epithelial cells. PLoS ONE. 2008, 3: e2369-10.1371/journal.pone.0002369.PubMedPubMedCentralCrossRef

31.

Lu Y, Ye L, Yu S, Zhang S, Xie Y, McKee MD, Li YC, Kong J, Eick JD, Dallas SL, Feng JQ: Rescue of odontogenesis in Dmp1-deficient mice by targeted re-expression of DMP1 reveals roles for DMP1 in early odontogenesis and dentin apposition in vivo. Dev Biol. 2007, 303: 191-201. 10.1016/j.ydbio.2006.11.001.PubMedPubMedCentralCrossRef

32.

Liu X, Lu R, Wu S, Sun J: Salmonella regulation of intestinal stem cells through the Wnt/beta-catenin pathway. FEBS Lett.

33.

Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, Chaffron S, Macpherson AJ, Buer J, Parkhill J: et al., Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007, 5: 2177-2189. 10.1371/journal.pbio.0050244.PubMedCrossRef

34.

Bruno VM, Hannemann S, Lara-Tejero M, Flavell RA, Kleinstein SH, Galan JE: Salmonella Typhimurium type III secretion effectors stimulate innate immune responses in cultured epithelial cells. PLoS Pathog. 2009, 5: e1000538-10.1371/journal.ppat.1000538.PubMedPubMedCentralCrossRef

35.

Hapfelmeier S, Ehrbar K, Stecher B, Barthel M, Kremer M, Hardt WD: Role of the Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice. Infect Immun. 2004, 72: 795-809. 10.1128/IAI.72.2.795-809.2004.PubMedPubMedCentralCrossRef

36.

Jones MA, Wood MW, Mullan PB, Watson PR, Wallis TS, Galyov EE: Secreted effector proteins of Salmonella dublin act in concert to induce enteritis. Infect Immun. 1998, 66: 5799-5804.PubMedPubMedCentral

37.

Galyov EE, Wood MW, Rosqvist R, Mullan PB, Watson PR, Hedges S, Wallis TS: A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa. Mol Microbiol. 1997, 25: 903-912. 10.1111/j.1365-2958.1997.mmi525.x.PubMedCrossRef

38.

Ehrbar K, Friebel A, Miller SI, Hardt WD: Role of the Salmonella pathogenicity island 1 (SPI-1) protein InvB in type III secretion of SopE and SopE2, two Salmonella effector proteins encoded outside of SPI-1. J Bacteriol. 2003, 185: 6950-6967. 10.1128/JB.185.23.6950-6967.2003.PubMedPubMedCentralCrossRef

39.

Zhou D, Galan J: Salmonella entry into host cells: the work in concert of type III secreted effector proteins. Microbes Infect. 2001, 3: 1293-1298. 10.1016/S1286-4579(01)01489-7.PubMedCrossRef

40.

Bakowski MA, Braun V, Brumell JH: Salmonella-containing vacuoles: directing traffic and nesting to grow. Traffic. 2008, 9: 2022-2031. 10.1111/j.1600-0854.2008.00827.x.PubMedCrossRef

41.

Wall DM, Nadeau WJ, Pazos MA, Shi HN, Galyov EE, McCormick BA: Identification of the Salmonella enterica serotype typhimurium SipA domain responsible for inducing neutrophil recruitment across the intestinal epithelium. Cell Microbiol. 2007, 9: 2299-2313. 10.1111/j.1462-5822.2007.00960.x.PubMedCrossRef

42.

Le Negrate G, Faustin B, Welsh K, Loeffler M, Krajewska M, Hasegawa P, Mukherjee S, Orth K, Krajewski S, Godzik A: et al., Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-kappaB, suppresses IkappaBalpha ubiquitination and modulates innate immune responses. J Immunol. 2008, 180: 5045-5056.PubMedCrossRef

43.

Rytkonen A, Poh J, Garmendia J, Boyle C, Thompson A, Liu M, Freemont P, Hinton JC, Holden DW: SseL, a Salmonella deubiquitinase required for macrophage killing and virulence. Proc Natl Acad Sci USA. 2007, 104: 3502-3507. 10.1073/pnas.0610095104.PubMedPubMedCentralCrossRef

44.

Coombes BK, Lowden MJ, Bishop JL, Wickham ME, Brown NF, Duong N, Osborne S, Gal-Mor O, Finlay BB: SseL is a salmonella-specific translocated effector integrated into the SsrB-controlled salmonella pathogenicity island 2 type III secretion system. Infect Immun. 2007, 75: 574-580. 10.1128/IAI.00985-06.PubMedPubMedCentralCrossRef

45.

Haraga A, Miller SI: A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1. Cell Microbiol. 2006, 8: 837-846. 10.1111/j.1462-5822.2005.00670.x.PubMedCrossRef

46.

Wu S, Ye Z, Liu X, Zhao Y, Xia Y, Steiner A, Petrof EO, Claud EC, Sun J: Salmonella typhimurium infection increases p53 acetylation in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2010, 298: G784-94. 10.1152/ajpgi.00526.2009.PubMedPubMedCentralCrossRef

47.

Sun J: Pathogenic Bacterial Proteins and their Anti-Inflammatory Effects in the Eukaryotic Host. Antiinflamm Antiallergy Agents Med Chem. 2009, 8: 214-227.PubMedPubMedCentralCrossRef

48.

Troyanovsky SM: Mechanism of cell-cell adhesion complex assembly. Curr Opin Cell Biol. 1999, 11: 561-566. 10.1016/S0955-0674(99)00021-6.PubMedCrossRef

49.

Darwin KH, Miller VL: Molecular basis of the interaction of Salmonella with the intestinal mucosa. Clin Microbiol Rev. 1999, 12: 405-428.PubMedPubMedCentral

50.

McCormick BA, Miller SI, Carnes D, Madara JL: Transepithelial signaling to neutrophils by salmonellae: a novel virulence mechanism for gastroenteritis. Infect Immun. 1995, 63: 2302-2309.PubMedPubMedCentral

51.

Takeuchi A: Electron microscope studies of experimental Salmonella infection. I. Penetration into the intestinal epithelium by Salmonella typhimurium. Am J Pathol. 1967, 50: 109-136.PubMedPubMedCentral

52.

Galan JE, Pace J, Hayman MJ: Involvement of the epidermal growth factor receptor in the invasion of cultured mammalian cells by Salmonella typhimurium. Nature. 1992, 357: 588-589. 10.1038/357588a0.PubMedCrossRef

53.

McCormick BA, Colgan SP, Delp-Archer C, Miller SI, Madara JL: Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J Cell Biol. 1993, 123: 895-907. 10.1083/jcb.123.4.895.PubMedCrossRef

54.

Gewirtz AT, Rao AS, Simon PO, Merlin D, Carnes D, Madara JL, Neish AS: Salmonella typhimurium induces epithelial IL-8 expression via Ca(2 +)-mediated activation of the NF-kappaB pathway. J Clin Invest. 2000, 105: 79-92. 10.1172/JCI8066.PubMedPubMedCentralCrossRef

55.

Finlay BB, Falkow S: Salmonella interactions with polarized human intestinal Caco-2 epithelial cells. J Infect Dis. 1990, 162: 1096-1106.PubMedCrossRef

56.

Francis CL, Starnbach MN, Falkow S: Morphological and cytoskeletal changes in epithelial cells occur immediately upon interaction with Salmonella typhimurium grown under low-oxygen conditions. Mol Microbiol. 1992, 6: 3077-3087. 10.1111/j.1365-2958.1992.tb01765.x.PubMedCrossRef

57.

Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, Hogardt M, Pfeffer K, Russmann H, Hardt WD: Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun. 2003, 71: 2839-2858. 10.1128/IAI.71.5.2839-2858.2003.PubMedPubMedCentralCrossRef

58.

Duan Y, Liao AP, Kuppireddi S, Ye Z, Ciancio MJ, Sun J: beta-Catenin activity negatively regulates bacteria-induced inflammation. Lab Invest. 2007, 87: 613-624. 10.1038/labinvest.3700497.PubMedCrossRef

59.

Kohler H, Sakaguchi T, Hurley BP, Kase BA, Reinecker HC, McCormick BA: Salmonella enterica serovar Typhimurium regulates intercellular junction proteins and facilitates transepithelial neutrophil and bacterial passage. Am J Physiol Gastrointest Liver Physiol. 2007, 293: G178-187. 10.1152/ajpgi.00535.2006.PubMedCrossRef

60.

Martinez-Argudo I, Jepson MA: Salmonella translocates across an in vitro M cell model independently of SPI-1 and SPI-2. Microbiology. 2008, 154: 3887-3894. 10.1099/mic.0.2008/021162-0.PubMedCrossRef

61.

Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, Nielsen H: Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology. 2009, 137: 495-501. 10.1053/j.gastro.2009.04.001.PubMedCrossRef

62.

Andoh A, Yagi Y, Shioya M, Nishida A, Tsujikawa T, Fujiyama Y: Mucosal cytokine network in inflammatory bowel disease. World J Gastroenterol. 2008, 14: 5154-5161. 10.3748/wjg.14.5154.PubMedPubMedCentralCrossRef

63.

Miller SI, Mekalanos JJ: Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J Bacteriol. 1990, 172: 2485-2490.PubMedPubMedCentral

64.

Hamilton CM, Aldea M, Washburn BK, Babitzke P, Kushner SR: New method for generating deletions and gene replacements in Escherichia coli. J Bacteriol. 1989, 171: 4617-4622.PubMedPubMedCentral

65.

Miller VL, Mekalanos JJ: A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol. 1988, 170: 2575-2583.PubMedPubMedCentral

66.

Boyd EF, Nelson K, Wang FS, Whittam TS, Selander RK: Molecular genetic basis of allelic polymorphism in malate dehydrogenase (mdh) in natural populations of Escherichia coli and Salmonella enterica. Proc Natl Acad Sci USA. 1994, 91: 1280-1284. 10.1073/pnas.91.4.1280.PubMedPubMedCentralCrossRef

67.

Lissner CR, Swanson RN, O'Brien AD: Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J Immunol. 1983, 131: 3006-3013.PubMed

68.

Sun J, Hobert ME, Rao AS, Neish AS, Madara JL: Bacterial activation of beta-catenin signaling in human epithelia. Am J Physiol Gastrointest Liver Physiol. 2004, 287: G220-227. 10.1152/ajpgi.00498.2003.PubMedCrossRef

69.

Sun J, Kong J, Duan Y, Szeto FL, Liao A, Madara JL, Li YC: Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab. 2006, 291: E315-322. 10.1152/ajpendo.00590.2005.PubMedCrossRef

70.

Komatsu M, Kobayashi D, Saito K, Furuya D, Yagihashi A, Araake H, Tsuji N, Sakamaki S, Niitsu Y, Watanabe N: Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. Clin Chem. 2001, 47: 1297-1301.PubMed

71.

Ye Z, Petrof EO, Boone D, Claud EC, Sun J: Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am J Pathol. 2007, 171: 882-892. 10.2353/ajpath.2007.070220.PubMedPubMedCentralCrossRef

72.

Hess J, Angel P, Schorpp-Kistner M: AP-1 subunits: quarrel and harmony among siblings. J Cell Sci. 2004, 117: 5965-5973. 10.1242/jcs.01589.PubMedCrossRef

73.

Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL: Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science. 2000, 289: 1560-1563. 10.1126/science.289.5484.1560.PubMedCrossRef

74.

Gewirtz AT, Simon PO, Schmitt CK, Taylor LJ, Hagedorn CH, O'Brien AD, Neish AS, Madara JL: Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest. 2001, 107: 99-109. 10.1172/JCI10501.PubMedPubMedCentralCrossRef

75.

Wu L, Estrada O, Zaborina O, Bains M, Shen L, Kohler JE, Patel N, Musch MW, Chang EB, Fu YX: et al., Recognition of host immune activation by Pseudomonas aeruginosa. Science. 2005, 309: 774-777. 10.1126/science.1112422.PubMedCrossRef

76.

Zaborina O, Lepine F, Xiao G, Valuckaite V, Chen Y, Li T, Ciancio M, Zaborin A, Petrof EO, Turner JR: et al., Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog. 2007, 3: e35-10.1371/journal.ppat.0030035.PubMedPubMedCentralCrossRef

77.

Green BT, Lyte M, Chen C, Xie Y, Casey MA, Kulkarni-Narla A, Vulchanova L, Brown DR: Adrenergic modulation of Escherichia coli O157:H7 adherence to the colonic mucosa. Am J Physiol Gastrointest Liver Physiol. 2004, 287: G1238-1246. 10.1152/ajpgi.00471.2003.PubMedCrossRef

78.

Bader MW, Sanowar S, Daley ME, Schneider AR, Cho U, Xu W, Klevit RE, Le Moual H, Miller SI: Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell. 2005, 122: 461-472. 10.1016/j.cell.2005.05.030.PubMedCrossRef

79.

Zhang S, Santos RL, Tsolis RM, Stender S, Hardt WD, Baumler AJ, Adams LG: The Salmonella enterica serotype typhimurium effector proteins SipA, SopA, SopB, SopD, and SopE2 act in concert to induce diarrhea in calves. Infect Immun. 2002, 70: 3843-3855. 10.1128/IAI.70.7.3843-3855.2002.PubMedPubMedCentralCrossRef

80.

Collier-Hyams LS, Zeng H, Sun J, Tomlinson AD, Bao ZQ, Chen H, Madara JL, Orth K, Neish AS: Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J Immunol. 2002, 169: 2846-2850.PubMedCrossRef

Title: The inflammatory cytokine tumor necrosis factor modulates the expression of Salmonella typhimurium effector proteins
Authors: Jun Ma
Yong-guo Zhang
Yinglin Xia
Jun Sun
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: Journal of Inflammation / Issue 1/2010
Electronic ISSN: 1476-9255
DOI: https://doi.org/10.1186/1476-9255-7-42

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The inflammatory cytokine tumor necrosis factor modulates the expression of Salmonella typhimurium effector proteins

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients

Characterization of protein tyrosine phosphatase H1 knockout mice in animal models of local and systemic inflammation

Neutrophil elastase downmodulates native G-CSFR expression and granulocyte-macrophage colony formation

Suppression of nitric oxide production from nasal fibroblasts by metabolized clarithromycin in vitro

Proposed protective mechanism of the pancreas in the rat

Anti-inflammatory effects and possible mechanism of action of lupeol acetate isolated from Himatanthus drasticus (Mart.) Plumel

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page